| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Christopher L Edwards, Mischca T Scales, Charles Loughlin, Gary G Bennett, Shani Harris-Peterson, Laura M De Castro, Elaine Whitworth, Mary Abrams, Miriam Feliu, Stephanie Johnson, Mary Wood, Ojinga Harrison, Alvin Killoug. A brief review of the pathophysiology, associated pain, and psychosocial issues in sickle cell disease. International journal of behavioral medicine. vol 12. issue 3. 2005-09-20. PMID:16083320. |
because tissue damage can occur at multiple foci, patients with scd are at risk for other medical complications including, but not limited to, delayed growth and sexual maturation; acute and chronic pulmonary dysfunction; stroke; aseptic necrosis of the hip, shoulders, or both; sickle cell retinopathy; dermal ulcers; and severe chronic pain. |
2005-09-20 |
2023-08-12 |
Not clear |
| A Adekile, M Z Haider, R Marouf, A D Adekil. HLA-DRB1 alleles in Hb SS patients with avascular necrosis of the femoral head. American journal of hematology. vol 79. issue 1. 2005-06-28. PMID:15849775. |
while stroke and silent brain infarcts (sbi) are unusual in kuwaiti children with scd, avascular necrosis of the femoral head (avnfh) is quite common. |
2005-06-28 |
2023-08-12 |
Not clear |
| J Makan. Stroke in sickle cell disease in Africa: case report. East African medical journal. vol 81. issue 12. 2005-06-07. PMID:15868983. |
stroke in scd is multifactorial, but high-risk individuals can be identified by simple well-established strategies such as transcranial doppler ultrasonography. |
2005-06-07 |
2023-08-12 |
Not clear |
| Béatrice Gulbis, David Haberman, Dominique Dufour, Catherine Christophe, Christiane Vermylen, Faustin Kagambega, Francis Corazza, Christine Devalck, Marie-Françoise Dresse, Kathleen Hunninck, Axel Klein, Phu Quoc Le, Michèle Loop, Philip Maes, Pierre Philippet, Eric Sariban, Chris Van Geet, Alina Ferste. Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience. Blood. vol 105. issue 7. 2005-05-03. PMID:15604217. |
there were 127 scd patients treated with no attempt to reach maximal tolerated doses who entered the belgian registry: 109 for standard criteria and 18 who were at risk of stroke only. |
2005-05-03 |
2023-08-12 |
Not clear |
| I Diagne, N R Diagne-Guèye, L Fall, O Ndiaye, B Camara, S Diouf, H Signate-Sy, N Kuakuv. [Acute encephalic manifestations in Senegalese children with sickle cell disease]. Dakar medical. vol 46. issue 2. 2005-04-26. PMID:15773177. |
the course of sickle cell disease (scd) may be complicated by neurologic events, mainly bactérial meningitidis and stroke. |
2005-04-26 |
2023-08-12 |
Not clear |
| I Diagne, N R Diagne-Guèye, L Fall, O Ndiaye, B Camara, S Diouf, H Signate-Sy, N Kuakuv. [Acute encephalic manifestations in Senegalese children with sickle cell disease]. Dakar medical. vol 46. issue 2. 2005-04-26. PMID:15773177. |
stroke appears to be rare in senegalese children with scd. |
2005-04-26 |
2023-08-12 |
Not clear |
| Caterina P Minniti, Vinod K Gidvani, Dorothy Bulas, Wendy A Brown, Gilbert Vezina, M Catherine Driscol. Transcranial Doppler changes in children with sickle cell disease on transfusion therapy. Journal of pediatric hematology/oncology. vol 26. issue 10. 2004-11-22. PMID:15454832. |
transcranial doppler (tcd) is an effective method for screening patients with sickle cell disease (scd) at risk for first stroke. |
2004-11-22 |
2023-08-12 |
Not clear |
| Kristin A Stegenga, Peggy Ward-Smith, Pamela S Hinds, Julie A Routhieaux, Gerald M Wood. Quality of life among children with sickle cell disease receiving chronic transfusion therapy. Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses. vol 21. issue 4. 2004-11-02. PMID:15490865. |
hemoglobin ss is the most severe form of scd and carries an increased risk for stroke. |
2004-11-02 |
2023-08-12 |
Not clear |
| George B Thurston, Nancy M Henderson, Michael Jen. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood. Clinical hemorheology and microcirculation. vol 30. issue 2. 2004-10-21. PMID:15004333. |
patients with sickle cell disease (scd) can experience severe complications, such as acute pain and stroke. |
2004-10-21 |
2023-08-12 |
Not clear |
| George B Thurston, Nancy M Henderson, Michael Jen. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood. Clinical hemorheology and microcirculation. vol 30. issue 1. 2004-09-30. PMID:14967885. |
patients with sickle cell disease (scd) can experience severe complications, such as acute pain and stroke. |
2004-09-30 |
2023-08-12 |
Not clear |
| Mehari Gebreyohanns, Robert J Adam. Sickle cell disease: primary stroke prevention. CNS spectrums. vol 9. issue 6. 2004-09-02. PMID:15162093. |
stroke is an important and common complication of sickle cell disease (scd), affecting children as well as adults. |
2004-09-02 |
2023-08-12 |
Not clear |
| Mehari Gebreyohanns, Robert J Adam. Sickle cell disease: primary stroke prevention. CNS spectrums. vol 9. issue 6. 2004-09-02. PMID:15162093. |
over 2,000 young children with scd were screened with transcranial doppler ultrasound (tcd) to detect elevated blood flow velocity indicative of vessel disease and high risk of future stroke. |
2004-09-02 |
2023-08-12 |
Not clear |
| Mehari Gebreyohanns, Robert J Adam. Sickle cell disease: primary stroke prevention. CNS spectrums. vol 9. issue 6. 2004-09-02. PMID:15162093. |
this approach is the only primary stroke prevention strategy so far tested in scd in a randomized controlled trial. |
2004-09-02 |
2023-08-12 |
Not clear |
| Heather J Fullerton, Robert J Adams, Shoujun Zhao, S Claiborne Johnsto. Declining stroke rates in Californian children with sickle cell disease. Blood. vol 104. issue 2. 2004-08-17. PMID:15054044. |
although the stroke prevention trial in sickle cell anemia (stop) demonstrated the efficacy of blood transfusions for primary stroke prevention in high-risk children with sickle cell disease (scd) in 1998, the impact of this trial on public health has not been studied. |
2004-08-17 |
2023-08-12 |
Not clear |
| Heather J Fullerton, Robert J Adams, Shoujun Zhao, S Claiborne Johnsto. Declining stroke rates in Californian children with sickle cell disease. Blood. vol 104. issue 2. 2004-08-17. PMID:15054044. |
our objective was to determine whether stroke rates in californian children with scd have declined since 1998. |
2004-08-17 |
2023-08-12 |
Not clear |
| Heather J Fullerton, Robert J Adams, Shoujun Zhao, S Claiborne Johnsto. Declining stroke rates in Californian children with sickle cell disease. Blood. vol 104. issue 2. 2004-08-17. PMID:15054044. |
using a california-wide hospital discharge database, we identified all first admissions for stroke in children with scd from 1991 through 2000. |
2004-08-17 |
2023-08-12 |
Not clear |
| Heather J Fullerton, Robert J Adams, Shoujun Zhao, S Claiborne Johnsto. Declining stroke rates in Californian children with sickle cell disease. Blood. vol 104. issue 2. 2004-08-17. PMID:15054044. |
annual stroke incidence rates were calculated as the number of admissions divided by the estimated population of californian children with scd in that year. |
2004-08-17 |
2023-08-12 |
Not clear |
| Heather J Fullerton, Robert J Adams, Shoujun Zhao, S Claiborne Johnsto. Declining stroke rates in Californian children with sickle cell disease. Blood. vol 104. issue 2. 2004-08-17. PMID:15054044. |
for 1991-2000, 93 children with scd were admitted to californian hospitals with a first stroke during 12 030 person-years of follow-up; 92.5% were ischemic and 7.5% hemorrhagic. |
2004-08-17 |
2023-08-12 |
Not clear |
| Heather J Fullerton, Robert J Adams, Shoujun Zhao, S Claiborne Johnsto. Declining stroke rates in Californian children with sickle cell disease. Blood. vol 104. issue 2. 2004-08-17. PMID:15054044. |
since the publication of the stop study in 1998, annual rates of admissions for first stroke for californian children with scd have declined. |
2004-08-17 |
2023-08-12 |
Not clear |
| Richard P Kennan, Sandra M Suzuka, Ronald L Nagel, Mary E Fabr. Decreased cerebral perfusion correlates with increased BOLD hyperoxia response in transgenic mouse models of sickle cell disease. Magnetic resonance in medicine. vol 51. issue 3. 2004-06-17. PMID:15004794. |
neurological complications such as stroke are known consequences of sickle cell disease (scd). |
2004-06-17 |
2023-08-12 |
mouse |